It is both nutritionally and pharmaceutically important if phlorotannins derived from edible brown seaweeds can inhibit Aβ aggregation and insulin glycation because those processes are closely related to the pathogenesis of AD. The gene discussed is INS; the disease is Alzheimer disease.